Abstract
In this issue of Blood, McKerrell et al describe a novel next-generation sequencing (NGS)-based platform for the identification of point mutations, common fusion genes, and copy-number alterations in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) from a single genomic DNA sample.
Original language | English |
---|---|
Pages (from-to) | 7-8 |
Number of pages | 2 |
Journal | Blood |
Volume | 128 |
Issue number | 1 |
DOIs |
|
Publication status | Published - 7 Jul 2016 |